Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Histologic Type × lutetium Lu 177 dotatate × 90 days × Clear all

Sponsor

Conditions

Neuroendocrine Tumors 8 Gastro-enteropancreatic neuroendocrine tumor 3 Pheochromocytoma 2 Paraganglioma 2 Meningioma 2 Adenoma, Islet Cell 2 Somatostatin Receptor-positive Neuroendocrine Tumor 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Metastatic Digestive System Neuroendocrine Tumor G1 1 Hypertension 1 Glioblastoma 1 Extensive Stage Small Cell Lung Cancer 1 Disease Progression 1 Advanced Lung Neuroendocrine Tumor 1

Interventions

fludarabine phosphate 2 fludarabine 2 Whole-Body Irradiation 2 Tacrolimus 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Mycophenolic Acid 2 Mesna 2 Melphalan 2 Cyclophosphamide 2 Cisplatin 2 Busulfan 2 trametinib 1 pralsetinib 1 ponatinib 1 pembrolizumab 1 durvalumab 1 dabrafenib 1 Radiotherapy, Intensity-Modulated 1 Pemetrexed 1 Paclitaxel 1 Nimorazole 1 Immunotherapy 1 Gemcitabine 1 Carboplatin 1 Bone Marrow Transplantation 1 Biopsy 1 Bevacizumab 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡